Skip to main content
. 2017 Mar 15;2017(3):CD012600. doi: 10.1002/14651858.CD012600

Kim 2006.

Clinical features and settings Routine screening
Participants 2570 participants with available outcome data
Korea ‐ hospital and womens healthcare centre
January 2001 to December 2001
Pregnant women
Mean age 29.9 years (SD 3.3 years)
Singleton pregnancies
10‐14 weeks' gestation
Study design Retrospective cohort
Target condition and reference standard(s) Down's syndrome: 31 cases
Reference standard: amniocentesis or CVS in 419 patients considered high risk (NT > 2.5, aged > 35 years, positive biochemical test result, history of chromosomal abnormality, fetal structural abnormality at ultrasound or other reason). Follow‐up to birth
Index and comparator tests First trimester NT (FMF methods) (HDI 3000, ATL, Bothell, WA, USA)
3 measurements taken, largest one used for risk calculation
Cut‐off 2.5 mm, 3.0 mm or 95th percentile of each CRL
Follow‐up Pregnancy outcomes ascertained from obstetric and neonatal medical records of live or stillborn babies
Only patients with known pregnancy outcome included in the study
8 patients who terminated their pregnancies because of structural abnormalities on ultrasound with no karyotyping results were excluded. Karyotyping was performed in intrauterine fetal death (n = 4) cases
Aim of study To determine the value of NT with different cut‐offs for the detection of chromosomal aberrations
Notes  
Table of Methodological Quality
Item Authors' judgement Description
Representative spectrum? 
 All tests Yes Routine screening of typical pregnant population 
Acceptable reference standard? 
 All tests Yes Karyotyping or follow‐up to birth
Partial verification avoided? 
 All tests Yes All women received a reference standard
Differential verification avoided? 
 All tests No Choice of reference standard depended on index test results
Incorporation avoided? 
 All tests Yes Reference standard was independent of the index test
Reference standard results blinded? 
 All tests No Reference standard interpreted with knowledge of index test results
Index test results blinded? 
 All tests Yes Index test interpreted without knowledge of reference standard results
Relevant clinical information? 
 All tests Yes Information available as would be in standard clinical practice 
Uninterpretable results reported? 
 All tests No No details given for test failures/uninterpretable measurements 
Withdrawals explained? 
 All tests No No details of withdrawals given